Sol-Gel Technologies Ltd (SLGL): Price Target Chart

The management of Sol-Gel Technologies (SLGL) masterfully utilizes silicon drug delivery technologies and intellectual property protection. Stability of component supplies is ensured through flexible routing and raw material stockpiles, as confirmed by the price action shown below, where the consensus forecast stands at 152.77. Meanwhile, the business strictly adheres to environmental regulations by implementing energy-saving systems in laboratories and the safe disposal of chemical waste.

sol-gel.com (SLGL) Price Target Chart: for the period 07/04/2022 - 11/11/2026

Analytical breakdowns for Sol-Gel (SLGL)

- price and consensus price forecast:

Market Chart sol-gel.com|SLGL - Price Target Chart

- stock exchange capitalization data:

Market Value Sol-Gel|SLGL - Enterprise Value

- issuer book value statistics:

Book Value of One Share Sol-Gel Technologies|SLGL - Company Book Value|Market Value to Book Value Ratio sol-gel.com|SLGL - Aggregate Company Assets

- debt obligations and liquidity statistics:

Aggregate Debt to Equity Sol-Gel Technologies|SLGL - Long-Term Debt to Capital|Ratio of Short-Term Indebtedness to Capital Sol-Gel Technologies, Ltd.|SLGL - Company Aggregate Debts|Debts to Book Capitalization Sol-Gel|SLGL - Company Long-Term Debt|Company Short-Term Loans and Borrowings Sol-Gel Technologies|Quick Liquidity Indicator sol-gel.com

- earnings and market multiples details:

SLGL - Net Profit|Projected Future Earnings Sol-Gel Technologies|SLGL - Price to Earnings Ratio|Future Price to Earnings Multiple Sol-Gel Technologies Ltd|SLGL - Price/Earnings to Growth Ratio|Total Company Value to Operating Income Before Depreciation Ratio Sol-Gel|SLGL - Profit before payment of interest, taxes and amortization|Net earnings per share (EPS TTM) Sol-Gel Technologies|SLGL - Net earnings per share (EPS TTM)|Year-over-year net earnings per share change for the last twelve months sol-gel.com|SLGL - Earnings per share growth in current year|Projected earnings per share growth rate for next year Sol-Gel Technologies

General company analysis:SLGL sol-gel.com

Flagship merchandise of Sol-Gel Technologies, Ltd.

This indicator represents the weighted average of target prices from leading institutional analysts, establishing an objective fundamental benchmark for the asset's value. The stability of Sol-Gel Technologies (SLGL) ingredient supply chains minimizes operational risks, allowing investors to utilize the current consensus valuation to determine the actual margin of safety and protect capital from market volatility.

Competitors of Sol-Gel Technologies

Analyst Median Target krystalbio.com|Price Target Chart Apogee Therapeutics, Inc. APGE|Arcutis - Price Target Chart|Vericel Corp. - Analyst Consensus Forecast|Analyst Target Range Oruka Pharma (ORKA)|sanaramedtech.com (SMTI) - Price Target Chart|DBVT (DBV Technologies) - Price Target Chart|Price Target Chart Solesence Beauty|Journey Medical Corp. - Forecast Levels Chart|Analyst Consensus Forecast FBRX|EMPG (Empro Corporation) - Fair Value Consensus|Analyst Consensus Forecast AXIL (AXIL Brands)|Analyst Consensus Forecast medicuspharma.com MDCX|VRCA - Price Target Chart|Fair Value Consensus HOTH (Hoth Therapeutics, Inc.)|biofrontera-us.com (BFRI) - Price Target Chart|Consensus Target VYNE Therapeutics Inc.|SNOA (Sonoma Pharmaceuticals Inc.) - Analyst Consensus Forecast|Analyst Consensus Forecast Quoin Pharma|Consensus Target AZTR (Azitra)|DRMA (Dermata Therapeutics Inc) - Fair Value Consensus|Price Target Chart Elevai Skincare ELAB|Analyst Median Target Revance Therapeutics Inc (RVNC)